Gainers
-
Top Image Systems Ltd. (NASDAQ: TISA)
shares climbed 55.43 percent to close at $0.83 on Monday after the company entered into a definitive agreement to be acquired
by Kofax for $0.86 per share in cash.
-
Maxwell Technologies Inc. (NASDAQ: MXWL) shares rose 49.51 percent to close at $4.59 after Tesla
Inc (NASDAQ: TSLA) announced plans to acquire
Maxwell Technologies for $4.75 per share.
-
PHI, Inc. (NASDAQ: PHII) shares gained
32 percent to close at $5.94.
-
StoneMor Partners L.P. (NYSE: STON)
shares rose 31.52 percent to close at $3.38 after reporting secured bank waiver and $35 million financing facility.
-
Horizon Global Corporation (NYSE: HZN)
gained 21.3 percent to close at $2.62.
-
Napco Security Technologies, Inc. (NASDAQ: NSSC) jumped 20.16 percent to close at $18.54 following Q2 earnings.
-
The Ultimate Software Group, Inc. (NASDAQ: ULTI) climbed 19.69 percent to close at $332.54 after the company agreed to be
acquired by Hellman & Friedman for $331.50 per share in cash.
-
Coffee Holding Co., Inc. (NASDAQ: JVA)
rose 18.34 percent to close at $7.29.
-
Eyenovia, Inc. (NASDAQ: EYEN) climbed
18.18 percent to close at $3.90 on Monday.
-
Therapix Biosciences Ltd. (NASDAQ: TRPX) shares rose 16.62 percent to close at $4.49.
-
Constellation Pharmaceuticals, Inc. (NASDAQ: CNST) surged 15.83 percent to close at $8.78 on Monday.
-
INSYS Therapeutics, Inc. (NASDAQ: INSY) rose 15.74 percent to close at $3.97.
-
Aemetis Inc (NASDAQ: AMTX) gained 15
percent to close at $1.15 after the company issued a notice of proposed award for a $5 million grant to the Aemetis Riverbank
cellulosic ethanol biorefinery.
-
Pyxus International, Inc. (NYSE: PYX)
climbed 14.96 percent to close at $17.06.
-
Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) climbed 14.88 percent to close at $3.32.
-
BioLineRx Ltd. (NASDAQ: BLRX) shares
gained 14.52 percent to close at $0.7341 after the company received Orphan Drug Designation from the FDA for BL-8040 for the
treatment of pancreatic cancer.
-
The Alkaline Water Company Inc. (NASDAQ: WTER) shares climbed 14.33 percent to close at $3.83 following a media report
mentioning alkaline stated cannabis beverages will likely be one of the biggest sellers in retail outlets.
-
Diebold Nixdorf, Incorporated (NYSE: DBD)
shares rose 14.22 percent to close at $4.98.
-
Arvinas Holding Company, LLC (NYSE: ARVN) shares surged 13.96 percent to close at $20.49.
-
Avadel Pharmaceuticals plc (NASDAQ: AVDL) jumped 13.26 percent to close at $3.16.
-
Aphria Inc. (NYSE: APHA) gained 12.68
percent to close at $10.84 after gaining 10.07 percent on Friday.
-
Evolus, Inc. (NASDAQ: EOLS) shares
rose 11.78 percent to close at $20.50 after the company's Jeuveau injection received FDA approval.
-
Cronos Group Inc. (NASDAQ: CRON)
gained 11.73 percent to close at $23.25.
-
Neptune Wellness Solutions Inc. (NASDAQ: NEPT) climbed 11.61 percent to close at $3.75. Neptune Wellness is expected to
release Q3 results on February 13, 2019.
-
Abeona Therapeutics Inc. (NASDAQ: ABEO) shares climbed 11.6 percent to close at $7.60.
-
MDJM Ltd. (NASDAQ: MDJH) shares gained
11.28 percent to close at $5.13.
-
Arcimoto, Inc. (NASDAQ: FUV) shares
surged 10.97 percent to close at $3.44.
-
AgeX Therapeutics, Inc. (NYSE: AGE) rose
10.92 percent to close at $4.47 on Monday.
-
Orgenesis Inc. (NASDAQ: ORGS) shares
climbed 10.76 percent to close at $4.94.
-
Covia Holdings Corporation (NYSE: CVIA)
jumped 10.56 percent to close at $5.34 on Monday.
-
Wrap Technologies, Inc. (NASDAQ: WRTC)
gained 10.41 percent to close at $4.03.
-
Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) rose 10.22 percent to close at $2.48.
-
BioXcel Therapeutics, Inc. (NASDAQ: BTAI) jumped 10.04 percent to close at $5.92. BioXcel Therapeutics expanded
indication for BXCL501 to treat symptoms associated with opioid drug withdrawal.
-
Ellie Mae, Inc. (NYSE: ELLI) climbed
9.89 percent to close at $83.99 following an unconfirmed media report the company may be exploring a sale.
-
Babcock & Wilcox Enterprises, Inc. (NYSE: BW) shares rose 9.06 percent to close at $0.6199 after the company successfully
sold and turned over its second project out of four that it expected to turn over in the first and second quarters of 2019.
-
Papa John's International, Inc. (NASDAQ: PZZA) gained 8.98 percent to close at $41.97 despite lowering earnings
expectations after hedge fund Starboard Equity made a $200 million investment in the company.
-
Sonos, Inc. (NASDAQ: SONO) shares
gained 7.23 percent to close at $13.05.
-
Clorox Co (NYSE: CLX) gained 5.69 percent
to close at $158.38 following upbeat quarterly earnings.
-
ZK International Group Co Ltd (NASDAQ: ZKIN) shares gained 4.32 percent to close at $1.69 after the company announced
record FY18 revenue of $54.9 million.
Losers
-
Check Cap Ltd (NASDAQ: CHEK) shares
declined 27.62 percent to close at $2.49 after the company announced an equity offering of 2.91 million shares and warrant
units at $2.58 per unit for a total of $7.5 million.
-
Medley Management Inc. (NYSE: MDLY)
shares dipped 23.08 percent to close at $3.80 on Monday after Nexpoint Advisors proposed merger transaction to Sierra Income
Corporation and Medley Capital Corporation boards.
-
OHR Pharmaceutical, Inc. (NASDAQ: OHRP) fell 23.05 percent to close at $1.97.
-
TMSR Holding Company Limited (NASDAQ: TMSR) shares dropped 18.84 percent to close at $4.4800.
-
Organogenesis Holdings Inc. (NASDAQ: ORGO) shares fell 14.12 percent to close at $11.98.
-
China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) shares dropped 13.51 percent to close at $5.76.
-
HyreCar Inc. (NASDAQ: HYRE) shares
fell 11.57 percent to close at $3.82.
-
Fortress Biotech, Inc. (NASDAQ: FBIO)
dropped 9.72 percent to close at $2.23.
-
Triton International Limited (NYSE: TRTN) fell 9.47 percent to close at $32.20 after Bank of America downgraded the
stock from Buy to Underperform and lowered the price target from $35 to $32.
-
Digital Ally, Inc. (NASDAQ: DGLY) fell
7.65 percent to close at $3.50.
-
ClearOne, Inc. (NASDAQ: CLRO) shares
slipped 7.62 percent to close at $1.94 on Monday.
-
Cool Holdings, Inc. (NASDAQ: AWSM)
dipped 7.37 percent to close at $2.64.
-
Fate Therapeutics, Inc. (NASDAQ: FATE)
dropped 7.32 percent to close at $14.05.
-
Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) shares slipped 6.1 percent to close at $6.46.
-
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) fell 5.58 percent to close at $2.37.
-
Norbord Inc. (NYSE: OSB) fell 5.11
percent to close at $28.58 after the company reported Q4 sales of $501 million versus the $532 million analyst estimate.
-
AngloGold Ashanti Limited (NYSE: AU)
shares fell 4.83 percent to close at $13.61 despite the company guiding FY18 EPS above analyst estimates.
© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.